Home / United Kingdom / Oxford Biomedica PLC

Oxford Biomedica PLC

Short position disclosed on October 19, 2026.

9.47% of the capital sold short

? funds not named

54 disclosures on record

GB00BDFBVT43 ISIN code

Since 13 July 2026 this regulator publishes an aggregated total per company and no longer names the funds. Positions disclosed before that date remain nominative.

Evolution of the disclosed total

0%2.5%5%7.5%10%

Jan 2026Apr 2026Jul 2026Oct 2026

Sum of open short positions, as % of capital. Hover or tap the curve to see which funds make it up.

Over the whole history, the total peaked at 9.47% on October 19, 2026. The shaded band matches the twelve months of the first chart.

March 20, 2015 today

Open positions

The funds disclosing a short position that is still open.
Fund	Twelve months	% of capital	Over the year	Since
Aggregated total		9.47%	new	October 19, 2026

In the United States OXBDF (OTC): 244,035 shares sold short on September 30, 2026. FINRA names no fund.

On the other side: the funds that hold Oxford Biomedica PLC Titelia

Follow by RSS

Get the moves on Oxford Biomedica PLC by mail, at most once a day.

There is no account to create. You give an address, you confirm it through a link, and every message contains a link to stop.

History of disclosures

54 disclosures on record for this share.
Date	Fund	% of capital
May 29, 2015	Wellington Management Company, LLP	1.05%
April 9, 2015	Millennium International Management LP	0.48%
April 8, 2015	Millennium International Management LP	0.57%
March 20, 2015	Millennium International Management LP	0.65%

Download 54 filings as CSV Columns: Date, Fund, Market, Disclosed position, Unit, End date. The other formats

Other companies sold short in the United Kingdom

Ceres Power Holdings PLC 18.02% of the capital sold short
Pennon Group PLC 15.10% of the capital sold short
Yellow Cake PLC 15.02% of the capital sold short
Ibstock PLC 14.13% of the capital sold short
Genuit Group PLC 12.86% of the capital sold short
Crest Nicholson Holdings PLC 12.05% of the capital sold short
Breedon Group Plc 11.72% of the capital sold short
Rightmove PLC 11.55% of the capital sold short
Chemring Group PLC 11.39% of the capital sold short
Capita PLC 11.21% of the capital sold short
WH Smith PLC 11.14% of the capital sold short
Wizz Air Holdings PLC 10.40% of the capital sold short

Cite this page

The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.

QuiVad, Oxford Biomedica PLC, source FCA, data as at October 19, 2026, https://www.quivad.com/action/oxford-biomedica-plc?page=2